Study on Consistency Evaluation for Drug Sensitivity of Patient-Derived Organoid Model From Cholangiocarcinoma Patients
Learn more about:
Related Clinical Trial
Liver Embolization Approaches for Tumor Management
Study on the Accuracy of Proteomics in Evaluating Lymph Node Metastasis Status in Cholangiocarcinoma Patients
Evaluation of the Patient’s Experience in Medical Studies for Cholangiocarcinoma
Looking At Bile Duct Cancer Patient Experience Patterns in Medical Trials
Advanced or Metastatic Cholangiocarcinoma
Study of [18F]FAPI-74 PET in Patients With Gastrointestinal Cancers
Study on Consistency Evaluation for Drug Sensitivity of Patient-Derived Organoid Model From Cholangiocarcinoma Patients
Screening Single-operator Cholangioscopy for Neoplastic Bile Duct Lesions
EUS-guided Choledochoduodenostomy for Primary Drainage of Malignant Distal Biliary Obstruction
An Exploratory Clinical Study of Photodynamic Therapy Combined With Sonodynamic Therapy in Cholangiocarcinoma
Bile Duct Drainage After ERCP Failure: EUS-BD vs PTBD
Safety and Efficacy of PDT vs RFA vs PDT+RFA for the Treatment of Extrahepatic Cholangiocarcinoma
FLUOPANC-trial – Fluorescence-guided Surgery of Pancreatic and Bileduct Tumors Using cRGD-ZW800-1
Phase Ib Trial of Infigratinib In Combination With Atezolizumab And Bevacizumab for The Second-Line Treatment of Advanced Cholangiocarcinoma With FGFR2 Fusion/Amplification
Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers
Minimally Invasive Pancreatoduodenectomy for Distal Cholangiocarcinoma
QoL After Liver Surgery
CH-EUS in Diagnosis of Inoperable Bile Duct Tumors
Treatment of ARB202 Advanced Gastrointestinal Cancer Patients
Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs
Implementation and Quality Assurance of DPYD-genotyping in Patients Treated With Fluoropyrimidines.
GEMOX Combined With Targeted Therapy and Immunotherapy for Patients With Advanced Cholangiocarcinoma
PD-1 Inhibitor Sintilimab Combined With Capecitabine for Adjuvant Treatment After Radical Resection of Cholangiocarcinoma.
Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors
Molecular Epidemiology of Biliary Tree Cancers
Prognostic Factors in Periampullary Tumors and Cysts
RALOX as Second Line Treatment for Advanced Malignant Biliary System Tumor
HLA Typing and Tumor Neoantigen Identification for a Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid Tumors
First in Human Study to Evaluate AZD8205 in Patients With Advanced or Metastatic Solid Malignancies
Early Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid Tumor
Deep Liver Phenotyping and Immunology Study
A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms
Radio Frequency Ablation in the Management of Pancreatico-biliary Disorders: A Multicenter Registry.
Maintenance Niraparib and Dostarlimab in Advanced Cholangiocarcinoma
A Phase I Study of WM-S1-030 in Patients With Advanced Solid Tumors
Niraparib Combined With Anlotinib in Homologous Recombination Repair (HRR) Gene-mutated Advanced Solid Tumors
The Comparison of Miniinvasive and Open Pancreaticoduodenectomy for Cancer Pancreaticobiliary Zone
Crossover Relative Bioavailability and Dose Escalation Study of TT-00420 Tablet in Patients With Advanced Solid Tumors
Neoadjuvant Bintrafusp Alfa in Patients With Resectable Biliary Tract Cancer
Open-Label Study for Safety, Tolerability, PK and Anti-Tumor Activity of STP705 Administered Intratumorally in Cholangiocarcinoma, Hepatocellular Carcinoma or Liver Metastases in Subjects With Advanced/Metastatic or Surgically Unresectable Solid Tumors Who Are Refractory to Standard Therapy
A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma
LYT-200 Alone and in Combination With Chemotherapy or Anti-PD-1 in Patients With Metastatic Solid Tumors
Lenvatinib in Patients With Previously Treated Advanced Biliary Tract Cancer
A Study of BMS-936558 With SBRT After Induction Chemotherapy in Cholangiocarcinoma
Apatinib Plus Camrelizumab in Patients With Previously Treated Advanced Biliary Tract Cancer
Phase I/II Study Evaluating Safety and Efficacy of Tivozanib (AV-951) in Cholangiocarcinoma
ENHANCED RECOVERY AFTER BILIARY TRACT SURGERY
Recurrence After Whipple’s (RAW): Retrospective Cohort Study Investigating Patterns of Cancer Recurrence Following Pancreaticoduodenectomy for Pancreatic Head Malignancy
Implementing Acupuncture and Chinese Herbal Medicine Into Palliative Care
Prospective Evaluation of Biliary Tissue Sampling With ERCP
Combination of Trametinib (MEK Inhibitor) and Hydroxychloroquine (HCQ) (Autophagy Inhibitor) in Patients With KRAS Mutation Refractory Bile Tract Carcinoma (BTC).
DNA Methylation Biomarker for Diagnosis of Cholangiocarcinoma in Patients With Bile Duct Stricture
Liver Cancer Registry Platform
Target Rare Cancer Knowledge
Neoadjuvant Therapy in Biliary Adenocarcinoma
BOLD-100 in Combination With FOLFOX for the Treatment of Advanced, Solid Tumours
the Impact of Early Palliative Care on the Survival of Locally Advanced and / or Metastatic Cholangiocarcinoma Patients
Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate Cancer
High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by Surgery
Short-term Starvation vs. Normal Diet Before Chemotherapy of Solid Tumors
Evaluation of MRI Sequences for Ultra-rapid Acquisition of Bile Ducts Images
Study of Oral Ceritinib in Patients With ALK and ROS1 Activated Gastrointestinal Malignancies
Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer
Improving Outcomes in Cancer Patients With a Nutritional and Physical Conditioning Prehabilitation Program
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
A Clinical Trial to Evaluate Safety and Efficacy of Endovascualr Denervation in Treatment of Cancer Pain
Comparison Between Internal and External Preoperative Biliary Drainage in Periampullary Cancers
A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors
Anesthetic Agents and Acute Kidney Injury After Liver Resection Surgery
Efficacy of Fistulotomy for Biliary Cannulation
A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors
Etomidate vs. Midazolam for Sedation During ERCP
Loop-tipped Guidewire in Selective Biliary Cannulation
Pancreatic Head and Peri-ampullary Cancer Laparoscopic vs Open Surgical Treatment Trial (PLOT)
Effects of OXY111A in Primary and Secondary Hepato-Pancreato-Biliary Neoplasm
BKM120 in Cancers With PIK3CA Activating Mutations
A First-in-human Phase Ia/b, Open Label, Multicentre, Dose Escalation Study of BI 905711 in Patients With Advanced Gastrointestinal Cancers
Infigratinib for the Treatment of Advanced or Metastatic Solid Tumors in Patients With FGFR Gene Mutations
Changes in Liver Function After Stereotactic Body Radiation Therapy Measured by PET/CT
PTFE Stents for Treatment of Malignant Biliary Strictures
Irreversible Electroporation of Unresectable Liver Tumors
Personal Resilience Empowerment Program Study
Radiofrequency Ablation for Biliopancreatic Malignancy
National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer
Early Enteral Feeding After Pylorus Preserving Pancreatoduodenectomy
Influence of an Oral Nutritional Supplement Rich in Omega-3 Fatty Acids on Functional State and Quality of Life in Malnourished Patients With Gastroenterological Tumors
In Vitro Models of Liver and Pancreatic Cancer
Biliary Tissue Sampling Using a Cytology Brush or the GIUM Catheter
Evaluation of Stereotactic Radiosurgery For Liver Malignancies
Beacon BNX™ Endoscopic Ultrasound (EUS)-Needle vs SharkCore™ Needle
A Pilot Study to Assess Theragnostically Planned Liver Radiation With Functional DVH Analysis to Optimize Individualized Radiation Therapy
Radiofrequency Ablation Using Octopus Electrodes for Treatment of Focal Liver Malignancies
Accuracy of Endoscopic Ultrasound for Detection of Tumors of the Liver
Prospective Study of the Risk of Bacteremia in Directed Cholangioscopic Examination of the CBD
Margin Status After Pancreaticoduodenectomy for Cancer
A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC)
Study of Olaparib and Durvalumab in IDH-Mutated Solid Tumors
Comparison Bile Duct Brushings, Cholangioscopy-Directed Biopsies and Pediatric Forceps Biopsies in Biliary Strictures
Effects of Preoperative Immunonutrition in Patients Undergoing Pancreaticoduodenectomy
A Study of BBI503 in Adult Patients With Advanced Hepatobiliary Cancer
A Study of TRK-950 in Patients With Advanced Solid Tumors
Combined HCC-MFCCC
Proton Therapy and Bevacizumab for Primary Liver Tumors
Effects of Preoperative Immunonutrition in Patients Undergoing Hepatectomy
Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer or Hepatic Metastases
Fluorescence QRH-882260 Peptide Imaging in the Bile Duct
A Phase 1 Study of ZSP1241 in Participants With Advanced Solid Tumors
pCLE For the Diagnosis Of Cancer in Unknown Bile Duct Stricture
Unilateral Versus Bilateral Stents for Bismuth Type II and III Malignant Hilar Strictures
Yttrium-90 Radioembolization Using Glass Microspheres (TheraSphere) for Patients With Liver Metastases
Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations
Study of Sildenafil as a Therapy for Fatigue in Pancreatic Cancer
Study of Gemcitabine With TheraSphere® (Yttrium-90)in Patients With Hepatic Tumors of Pancreatobiliary Origin
Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function
Phase 1 In-vivo Biliary Study of KSP/QRH Heptapeptide Dimer
Safety and Efficacy of Modified Folfirinox Versus Gemcis in Bile Duct Tumours
MRCP Diagnoses EHCC Better When Combined DWI
Comparison of Biliary Forceps Biopsy and Brush Cytology
Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal Cancers
Pilot Study of Irreversible Electroporation (IRE) to Treat Metastatic Liver Cancer & Cholangiocarcinoma
Endoscopic Bipolar Radiofrequency Probe (ENDOHPB) in the Management of Unresectable Bile Duct and Pancreatic Cancer
A Registry of Patients Undergoing Cellvizio Endomicroscopy and Endoscopic Retrograde Cholangiopancreatography(ERCP) Imaging Procedures for Diagnosing Pancreatic and Bile Duct Cancers
Cyclooxygenase-2 Inhibitor for Adjuvant Anticancer Effect in Patients With Biliary-pancreas Cancer
Endobiliary RFA for Unresectable Malignant Biliary Strictures
A Clinical Trial of Entinostat in Combination With Nivolumab for Patients With Previously Treated Unresectable or Metastatic Cholangiocarcinoma and Pancreatic Adenocarcinoma
Clinical Effect and Safety of PDT and RFA for Unresectable EHCC
Safety and Efficiency of Photodynamic Therapy for Blie Duct Carcinoma
Gemcitabine With Peptide Vaccine Therapy in Treating Patients With Bile Duct Cancer
A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma
Trial of IRE in Cholangiocarcinoma
Intra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From Cholangiocarcinoma
Chemo Alone or in Combination With Radiation in Unresectable Cholangiocarcinoma
ASLAN001 in Patients With Advanced or Metastatic Cholangiocarcinoma Who Progressed on at Least 1 Line of Systemic Therapy
A Study of Gemcitabine as an Adjuvant Treatment for Cholangiocarcinoma After Surgical Resection
Efficiency Evaluation of Photodynamic Therapy With Photofrin® on Unresectable Type III or IV Cholangiocarcinomas
PCI Treatment/Gemcitabine & Chemotherapy vs Chemotherapy Alone in Patients With Inoperable Extrahepatic Bile Duct Cancer
S-1 in Combination With Abraxane in Treating Cholangiocarcinoma
Phase II Trial of Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients With Cholangiocarcinoma
Combination Chemotherapy Plus Panitumumab or Bevacizumab for Inoperable Cholangiocarcinoma Without KRAS Mutations
A Phase I/II Safety and Efficacy Study of PCI of Gemcitabine and Chemotherapy in Patients With Cholangiocarcinomas
Comparison of Endoscopic Radiofrequency Ablation Versus Photodynamic Therapy for Inoperable Cholangiocarcinoma
Diagnosis, Treatment Status and Prognosis of Cholangiocarcinoma in China: a Multicenter, Two-way, Non-intervention Study
Gemcitabine/Oxaliplatin and Photodynamic Therapy in Cholangiocarcinoma
Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy – (FIGHT-202)
Pemigatinib in Treating Patients With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Including FGFR2 Rearrangement
Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cholangiocarcinoma
Chart Review: Unresectable/Metastatic Cholangiocarcinoma Treated With Irinotecan, Capecitabine and Celecoxib
Neoadjuvant mFOLFOXIRI for Potentially Resectable Cholangiocarcinoma
Study of TRIFLURIDINE/TIPIRACIL in Previously Treated Cholangiocarcinoma
Study Of Intrahepatic Arterial Injection of 90-Y Glass Microspheres for Cholangiocarcinoma
Combined Biological Treatment and Chemotherapy for Patients With Inoperable Cholangiocarcinoma
Gemcitabine, Oxaliplatin and Capecitabine in Patients With Advanced Cholangiocarcinoma
Registry Study of Neoadjuvant Chemoradiation & Transplant for Cholangiocarcinoma Patients
Study of RAD001 in Advanced Cholangiocarcinoma: RADiChol
Study of Pembrolizumab and Olaparib in Bile Duct Cancer
Cohort of Patients With Hepatocellular Carcinoma or Cholangiocarcinoma
Second Line Chemotherapy FOLFIRINOX in Irresectable Cholangiocarcinoma
ncRNAs in Exosomes of Cholangiocarcinoma
Single Arm Study of RAD001 as Monotherapy in Treatment in Advanced Cholangiocarcinoma
Trial of Therapeutic Vaccine in Patients With Cholangiocarcinoma